Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
905.00    9.00 (1.00%)
Bid:
905.00
Ask:
906.00
Spread: 1.00 (0.11%)
Market Cap: £130.21b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 2-8Oct

9 Oct 2025 11:05

RNS Number : 7603C
Banco Santander S.A.
09 October 2025
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Reference is made to our notice of inside information of 30 July 2025 (official registry number 2844) (the "Buyback Commencement Communication"), relating to the buyback programme of own shares (the "Buyback Programme") approved by the Board of Directors of Banco Santander.

 

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 2 and 8 October 2025 (both inclusive).

 

The cash amount of the shares purchased to 8 October 2025 as a result of the execution of the Buyback Programme amounts to 603,268,044 Euros, which represents approximately 35.5% of the maximum investment amount of the Buyback Programme. The programme was announced together with its other characteristics through the Buyback Commencement Communication. With these purchases, the Bank has repurchased approximately 14.6% of its outstanding shares as of 2021.

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

02/10/2025

SAN

Purchase

XMAD

1,652,572

8.7684

02/10/2025

SAN

Purchase

CEUX

103,730

8.7983

02/10/2025

SAN

Purchase

TQEX

21,792

8.8018

02/10/2025

SAN

Purchase

AQEU

21,906

8.8044

03/10/2025

SAN

Purchase

XMAD

1,062,295

8.7727

03/10/2025

SAN

Purchase

CEUX

95,764

8.7710

03/10/2025

SAN

Purchase

TQEX

20,346

8.7717

03/10/2025

SAN

Purchase

AQEU

21,595

8.7708

06/10/2025

SAN

Purchase

XMAD

1,255,767

8.7037

06/10/2025

SAN

Purchase

CEUX

69,710

8.7096

06/10/2025

SAN

Purchase

TQEX

38,194

8.7124

06/10/2025

SAN

Purchase

AQEU

36,329

8.7214

07/10/2025

SAN

Purchase

XMAD

1,535,134

8.6447

07/10/2025

SAN

Purchase

CEUX

96,482

8.6579

07/10/2025

SAN

Purchase

TQEX

22,104

8.6490

07/10/2025

SAN

Purchase

AQEU

46,280

8.6648

08/10/2025

SAN

Purchase

XMAD

1,437,486

8.7052

08/10/2025

SAN

Purchase

CEUX

96,666

8.7003

08/10/2025

SAN

Purchase

TQEX

24,895

8.6924

08/10/2025

SAN

Purchase

AQEU

40,953

8.7010

TOTAL

7,700,000

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

 

Boadilla del Monte (Madrid), 9 October 2025

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 02/10/2025 and 08/10/2025 (both inclusive)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPGGUUUPAGUB
Date   Source Headline
6th May 20257:00 amRNSAnalysts meeting announcement
30th Apr 202512:41 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNS1Q 2025 Results report & analyst presentation
30th Apr 20257:00 amRNS1Q 2025 Results Press Release
29th Apr 202511:11 amRNSBuyback programme: Transactions 23-28Apr
28th Apr 20251:56 pmRNSSantander statement
23rd Apr 202511:59 amRNS1st Quarter 2025 Results Notice
23rd Apr 202511:11 amRNSBuyback programme: transactions 11-22Apr
11th Apr 202511:13 amRNSBuyback programme: transactions 3-10Apr
4th Apr 20253:09 pmRNS2025 AGM - Resolutions
4th Apr 20257:08 amRNSSantander expects growth & 2025 targets reaffirmed
3rd Apr 202511:13 amRNSBuyback programme: transactions 27Mar-2Apr
31st Mar 20254:07 pmRNSTotal Voting Rights
27th Mar 202511:15 amRNSTransaction in Own Shares
20th Mar 202511:10 amRNSBuyback programme: transactions 13Mar-19Mar
17th Mar 20255:31 pmRNSDirector/PDMR Shareholding
14th Mar 20251:27 pmRNSDirector/PDMR Shareholding
14th Mar 20251:22 pmRNSDirector/PDMR Shareholding
13th Mar 202511:06 amRNSBuyback programme: transactions 6 Mar -12 Mar
6th Mar 202511:14 amRNSBuyback programme: transactions 27 Feb- 5 Mar
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20256:23 pmRNSDirector/PDMR Shareholding
28th Feb 20256:19 pmRNSDirector/PDMR Shareholding
28th Feb 20256:14 pmRNSDirector/PDMR Shareholding
28th Feb 20256:08 pmRNSDirector/PDMR Shareholding
28th Feb 202510:52 amRNSTotal Voting Rights
28th Feb 202510:51 amRNSNotice of AGM
28th Feb 202510:15 amRNS2024 UK Annual Report
27th Feb 202511:12 amRNSBuyback programme: transactions 20Feb-26Feb
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDividend declaration & agreement to call 2025 AGM
20th Feb 202511:12 amRNSBuyback programme: transactions 13Feb-19Feb
19th Feb 20255:46 pmRNSDirector/PDMR Shareholding
14th Feb 20251:10 pmRNSReplaces Invitation to purchase certain instrument
13th Feb 202512:00 pmRNSInvitation to purchase certain instruments
13th Feb 202511:18 amRNSBuyback programme: transactions 6Feb-12Feb
12th Feb 20253:43 pmRNSRating granted by Fitch Ratings
7th Feb 20251:49 pmRNSDirector/PDMR Shareholding
7th Feb 20251:48 pmRNSDirector/PDMR Shareholding
6th Feb 20258:00 amRNSInvitation to purchase certain instruments
5th Feb 20257:00 amRNS2024 Financial report & Earnings presentation
5th Feb 20257:00 amRNS2024 Results - Press release
5th Feb 20257:00 amRNSCommencement of a program to repurchase own shares
31st Jan 20251:14 pmRNSTotal Voting Rights
29th Jan 202512:44 pmRNSForm 8.3 - Smith (DS) PLC
29th Jan 202511:07 amRNSNotice of 2024 Results Presentation
23rd Jan 20254:03 pmRNSInvitation to purchase certain instruments
20th Jan 20259:28 amRNSOptional early redemption ISIN XS1793250041

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.